Difference between revisions of "ENDO5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
Line 16: | Line 16: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
+ | |- | ||
+ | |CHAPTER 2 (PITUITARY TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]] | |[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]] | ||
Line 258: | Line 278: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 3 (THYROID TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]] | |[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]] | ||
Line 533: | Line 573: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 4 (PARATHYROID TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]] | |[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]] | ||
Line 588: | Line 648: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 5 (ADRENAL GLAND TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Adrenal_rests|Adrenal rests]] | |[[ENDO5:Adrenal_rests|Adrenal rests]] | ||
Line 698: | Line 778: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Neuroblastoma|Neuroblastoma]] | |[[ENDO5:Neuroblastoma|Neuroblastoma]] | ||
Line 786: | Line 886: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]] | |[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]] | ||
Line 907: | Line 1,027: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]] | |[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]] | ||
Line 984: | Line 1,124: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Lipoma|Lipoma]] | |[[ENDO5:Lipoma|Lipoma]] | ||
Line 1,127: | Line 1,287: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:IgG4-related_disease|IgG4-related disease]] | |[[ENDO5:IgG4-related_disease|IgG4-related disease]] | ||
Line 1,204: | Line 1,384: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 11 (GERM CELL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]] | |[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]] | ||
Line 1,226: | Line 1,426: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 12 (METASTASIS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]] | |[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]] | ||
Line 1,259: | Line 1,479: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]] | |[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]] |
Revision as of 11:21, 26 February 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.